866-997-4948(US-Canada Toll Free)

Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016

Published By :

DelveInsight

Published Date : Feb 2016

Category :

Therapeutic Area

No. of Pages : 338 Pages

DelveInsight

Table of Contents:

Head and Neck Squamous Cell Carcinoma Overview
Epidemiology
Diagnosis of Head and Neck Cancer
Market Scenario
Market Barriers
Market Drivers
Pipeline Therapeutics
An Overview of Pipeline Products for Head and Neck Squamous Cell Carcinoma
Therapeutics under Development by Companies
Last Stage Products (Phase III)
Comparative Analysis
Mid Stage Products (Phase II)
Comparative Analysis
Early Stage Products (Phase I and IND)
Comparative Analysis
Phase 0 stage Products
Comparative Analysis
Discovery and Pre-clinical stage Products
Comparative Analysis
Therapeutic Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Discontinued Products
Dormant Products
Companies Involved in Therapeutics Development

Appendix
DelveInsight Consulting Services
About DelveInsight
Contact Us
Disclaimer

List of Table

Table 1: Number of Products Under Development for Head and Neck Squamous Cell Carcinoma, 2016
Table 2: Number of Products under Development by Companies, 2016
Table 3: Last Stage Products (Phase III and Filed), 2016
Table 4: Mid Stage Products (Phase II), 2016
Table 5: Early Stage Products (Phase I and IND), 2016
Table 6: Phase 0 stage Products , 2016
Table 7: Discovery and Pre-clinical Stage Products , 2016
Table 8: Assessment by Monotherapy Products,2016
Table 9: Assessment by Route Of Administration, 2016
Table 10: Assessment by Stage and Route Of Administration, 2016
Table 11: Assessment by Molecule Type, 2016
Table 12: Assessment by Stage and Molecule Type, 2016
Table 13: Discontinued Products, 2016
Table 14: Dormant Products, 2016
Table 15: Companies Involved in Therapeutic Development, 2016

List of Chart

Figure 1: Percent of New Cases by Age Group: Head and Neck Cancer, 2016
Figure 2: Percent of Deaths by Age Group:  Head and Neck Cancer, 2016
Figure 3: Number of Products under Development Head and Neck Squamous Cell Carcinoma, 2016
Figure 4: Last Stage Products (Phase III) 2016
Figure 5: Mid Stage Products (Phase II), 2016
Figure 6: Early Stage Products (Phase I and IND), 2016
Figure 7: Phase 0 stage Products, 2016
Figure 8: Discovery and Pre-clinical Stage Products, 2016
Figure 9: Assessment by Monotherapy Products, 2016
Figure 10: Assessment by Combination Products, 2016
Figure 11: Assessment by Route of Administration, 2016
Figure 12: Assessment by Stage and Route of Administration, 2016
Figure 13: Assessment by Molecule Type, 2016
Figure 14: Assessment by Stage and Molecule Type, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *